≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback
info icon

Seminoma of testis

Endpoint Browser

C3_TESTIS_SEMINOMA

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

557745

1. Apply sex-specific rule

only males

244368

2. Check conditions

None

244368

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cause of death: ICD-10 — C62.01&, C62.11&, C62.91&
  • Cause of death: ICD-9 — 186A
  • Cancer registry: Topography ICD-O-3 — C62
  • Cancer registry: Morphology ICD-O-3 — 9061
  • Cancer registry: Behaviour codes — 3

2 out of 7 registries used, show all original rules.

342

4. Check minimum number of events

None

342

5. Include endpoints

None

342

6. Filter based on genotype QC (FinnGen only)

299

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze
DF9

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 299 - 299
Unadjusted period prevalence (%) 0.14 - 0.14
Median age at first event (years) 37.18 - 37.18

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
319
Matched controls
3190
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C62.11
ICD-10 Finland
Malignant tumor of the descending testicle, seminoma
+∞
302.3
240
*
9061/3-C62.9
ICD-O-3
Seminoma, NOS, of testis, NOS
+∞
288.0
231
*
KFC00
NOMESCO Finland
Unilateral orchiectomy
1244.4
267.5
225
6
D40.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Testis
1088.5
209.8
183
*
JN4BD
NOMESCO Finland
Extensive body CT
34.0
183.0
131
64
JN4AD
NOMESCO Finland
Body CT examination
19.8
115.4
101
73
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
17.4
102.1
95
76
A03FA01
ATC
metoclopramide; systemic, rectal
13.6
96.2
107
114
130
Kela drug reimbursment
Malignant tumour
+∞
95.8
87
*
9061/3-C62.1
ICD-O-3
Seminoma, NOS, of descended testis
+∞
87.6
80
*
C62.10
ICD-10 Finland
Malignant tumor of the descending testicle, no histological verification
+∞
57.0
53
*
KFH50
NOMESCO Finland
Insertion of prosthetic replacement for testis
518.2
46.5
45
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
46.0
43
*
C62.1
ICD-10 Finland
Malignant neoplasm: Descended testis
+∞
44.9
42
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
7.1
39.9
69
120
H02AB02
ATC
dexamethasone; systemic
57.9
38.7
45
9
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
38.3
36
*
C62.91
ICD-10 Finland
Malignant tumor in unspecified location in testis, seminoma
+∞
35.0
33
*
18699
ICD-8 Finland
Malignant neoplasm of testis
+∞
35.0
33
*
WZC00
NOMESCO Finland
Treatment plan or consultation
3.9
31.0
147
576
7511
FHL
Orchidectomy (unilateral), also includes funicularectomy
332.2
30.3
30
*
JN3AD
NOMESCO Finland
Abdominal CT examination
5.1
30.3
76
185
C62.01
ICD-10 Finland
Malignant tumor of the non-descending testicle, seminoma
+∞
29.6
28
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.6
28.2
192
938
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
26.4
25
*
121
Kela drug reimbursment
Severe hypofunction of sexual glands
26.0
25.4
35
15
WF002
NOMESCO Finland
Radical radiotherapy
+∞
24.3
23
*
A04AA01
ATC
ondansetron; systemic, rectal
21.7
24.1
35
18
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
23.2
22
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.4
21.9
63
169
C62.19
ICD-10 Finland
Malignant tumor of the descending testicle, other or undetermined histology
+∞
21.1
20
*
C62.00
ICD-10 Finland
Malignant tumor of the non-descending testicle, no histological verification
+∞
21.1
20
*
L03AA02
ATC
filgrastim; parenteral
224.0
20.8
21
*
XX3DW
NOMESCO Finland
Time consuming IT work
7.3
20.8
32
48
WX408
NOMESCO Finland
General anesthesy, balanced
3.4
20.8
100
381
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
4.4
20.7
58
152
C62.99
ICD-10 Finland
Malignant tumor in unspecified location in testis,other or undetermined histology
+∞
20.0
19
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
20.0
19
*
C62.90
ICD-10 Finland
Malignant tumor in unspecified location in testis, no histological verification
+∞
20.0
19
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
201.3
18.7
19
*
L01BC06
ATC
capecitabine; oral
+∞
17.9
17
*
1869A
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROTALIS),SEMINOMA]
+∞
17.9
17
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
190.1
17.7
18
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
190.1
17.7
18
*
N02AA05
ATC
oxycodone; systemic
4.0
16.7
52
147
E29.1
ICD-10 Finland
Testicular hypofunction
6.3
16.5
29
50
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
15.8
15
*
C62.12
ICD-10 Finland
Malignant tumor of the descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
15.8
15
*
N46
ICD-10 Finland
Male infertility
5.6
15.2
30
58
ZXE00
NOMESCO Finland
One hour or less
2.7
15.1
122
604
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
84.1
14.7
16
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
14.7
14
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
14.7
14
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
12.6
12
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.1
12.3
59
219
ZXE10
NOMESCO Finland
More than one and less than three hours
2.4
11.9
107
547
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
11.5
11
*
Y78
ICPC
Malign neopl male genital other
+∞
11.5
11
*
Z85.4
ICD-10 Finland
Personal history of malignant neoplasm of genital organs
+∞
11.5
11
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
11.5
11
*
D29.2
ICD-10 Finland
Benign neoplasm: Testis
36.5
11.4
14
*
WX402
NOMESCO Finland
General anaesthesia
2.6
11.1
76
340
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.4
11.0
42
135
JN4CD
NOMESCO Finland
Very extensive body CT
14.9
10.6
17
12
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
10.5
10
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
10.5
10
*
C62.9
ICD-10 Finland
Malignant neoplasm: Testis, unspecified
+∞
10.5
10
*
ZXD10
NOMESCO Finland
Scheduled procedure
2.3
10.4
106
567
WX320
NOMESCO Finland
Spinalanesthesy
2.5
10.0
71
322
D70.82
ICD-10 Finland
Drug-induced neutropenia
27.0
9.9
13
5
WX302
NOMESCO Finland
Thoracal epidural anesthesy
8.2
9.8
21
27
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
56.8
9.7
11
*
L03AA13
ATC
pegfilgrastim; parenteral
103.0
9.5
10
*
C62
ICD-10 Finland
Malignant neoplasm of testis
+∞
9.4
9
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
9.4
9
*
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
11.2
9.4
17
16
Z51.5
ICD-10 Finland
Palliative care
6.9
8.8
21
32
WZC30
NOMESCO Finland
Teaching
2.7
8.8
52
215
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
5.0
8.7
19
40
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
4.3
8.4
22
54
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
8.4
8
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
8.4
8
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
+∞
8.4
8
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
+∞
8.4
8
*
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
+∞
8.4
8
*
9061/3-C62.0
ICD-O-3
Seminoma, NOS, of undescended testis
+∞
8.4
8
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.6
7.9
26
76
2395A
ICD-9 Finland
Neoplasm of unspecified nature, Other genito-urinary organs
46.1
7.7
9
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
7.3
7
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
7.3
7
*
C62.0
ICD-10 Finland
Malignant neoplasm: Undescended testis
+∞
7.3
7
*
A04AD12
ATC
aprepitant; systemic
+∞
7.3
7
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
7.3
7
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
16.2
7.3
11
7
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.9
6.9
33
121
WW500
NOMESCO Finland
Blood transfusion
8.6
6.9
14
17
B01AB10
ATC
tinzaparin; parenteral
3.2
6.6
26
85
ZX120
NOMESCO Finland
Intravenous
3.1
6.5
28
97
7513
FHL
Test prosthesis installation
71.2
6.4
7
*
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
3.4
6.4
23
71
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
8.4
6.4
13
16
KA1FN
NOMESCO Finland
Isotope renography
18.5
6.3
9
5
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
6.3
6
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
+∞
6.3
6
*
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
6.3
6
*
1869X
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROTALIS),EI HIST VAHV]
+∞
6.3
6
*
E89.5
ICD-10 Finland
Postprocedural testicular hypofunction
+∞
6.3
6
*
N02BE01
ATC
paracetamol; systemic, rectal
2.2
6.2
269
2266
TPX10
NOMESCO Finland
Implantation of vascular injection port
7.9
6.2
13
17
R50.9
ICD-10 Finland
Fever, unspecified
2.2
6.1
55
275

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
166
30
114.28
311.35
8.2
2.5
95.19
2.88
u/ml
0.50
158
30
184
9
484.59
204.04
9.6
1.1
17.49
—
u/l
—
52
0
75
40
24.21
98.32
3.9
1.3
16.50
8.96
iu/l
1.42
62
26
101
109
13.10
89.60
3.4
1.4
7.65
3.99
u/l
2.60
86
90
74
64
14.75
75.00
1.2
1.3
—
—
—
0
0
145
627
3.41
25.22
2.3
1.6
—
—
—
0
0
87
280
3.90
23.69
1.4
1.8
—
—
—
0
0
228
1327
3.52
23.62
11.8
8.1
3.66
4.27
e9/l
3.69
201
1164
89
327
3.39
19.47
5.3
1.9
2.43
2.42
mmol/l
0.56
79
281
129
613
2.85
17.78
5.5
2.1
2.36
2.35
mmol/l
0.49
121
551
160
857
2.74
17.39
3.0
2.4
—
—
estimate
—
0
0
40
90
4.94
17.12
7.5
2.0
4.40
2.41
ug/l
1.66
35
71
97
402
3.03
17.09
1.8
1.6
—
—
—
0
0
147
772
2.68
16.38
6.0
6.3
—
—
—
0
0
120
573
2.75
16.11
3.7
2.8
0.65
0.23
e6/l
0.47
92
420
59
189
3.60
15.76
1.4
1.1
—
—
—
0
0
132
675
2.63
15.30
3.9
2.8
101.22
135.24
e6/l
0.11
103
517
93
407
2.81
14.57
1.9
1.9
—
—
—
0
0
113
553
2.62
14.14
3.8
2.7
—
0.00
estimate
—
0
5
35
84
4.56
13.81
1.5
2.2
21.03
20.60
s
0.38
35
77
140
770
2.46
13.55
4.2
3.3
56.33
133.16
e6/l
0.64
108
552
177
1106
2.35
12.54
6.8
6.6
3.08
3.09
%
0.02
167
1058
208
1397
2.41
12.41
5.9
5.3
6.64
6.90
mmol/l
0.76
198
1341
115
598
2.44
12.38
1.3
1.3
—
—
—
0
0
177
1110
2.34
12.38
6.9
6.6
0.66
0.70
%
0.39
167
1060
177
1111
2.33
12.34
6.9
6.7
8.95
9.09
%
0.28
167
1061
156
933
2.32
12.13
9.3
4.6
36.51
36.97
g/l
0.44
144
874
115
603
2.42
12.11
2.1
2.1
—
—
—
0
0
187
1224
2.28
11.51
6.7
6.7
0.58
0.61
e9/l
0.71
153
1069
180
1160
2.27
11.50
6.7
6.5
26.36
27.78
%
0.94
170
1117
165
1027
2.26
11.47
12.5
7.0
1.20
1.20
mmol/l
0.03
133
909
168
1058
2.24
11.29
11.9
9.7
0.00
0.00
e9/l
0.23
136
871
75
332
2.65
11.21
3.7
2.6
0.35
0.44
e6/l
0.21
44
157
186
1226
2.24
11.11
6.7
6.7
0.04
0.04
e9/l
2.20
153
1078
189
1259
2.23
10.93
6.7
6.7
1.60
1.90
e9/l
5.38
159
1122
189
1266
2.21
10.69
6.9
7.0
0.18
0.21
e9/l
1.61
160
1119
147
904
2.16
10.19
10.9
6.7
1.21
1.20
mmol/l
0.65
142
843
173
1147
2.11
9.71
6.7
6.4
58.59
56.88
%
1.08
166
1114
88
462
2.25
8.86
2.9
2.4
2.96
2.29
e6/l
0.43
80
421
113
658
2.11
8.74
10.2
4.8
—
—
—
0
0
79
399
2.30
8.70
3.6
2.5
589.88
566.57
mosm/kgh2o
0.41
73
354
106
606
2.12
8.58
3.4
2.1
—
—
—
0
0
105
621
2.03
7.62
7.6
4.1
—
—
—
0
0
19
45
4.43
7.58
2.1
3.5
37.95
44.07
%
0.58
19
45
19
45
4.43
7.58
4.2
6.9
10.58
8.38
%
0.77
19
45
89
507
2.05
7.10
1.9
1.7
1.10
0.93
mg/l
0.28
66
373
97
576
1.98
6.86
8.3
3.7
7.39
7.40
ph
0.50
72
411
51
240
2.34
6.52
2.5
2.0
202.63
250.12
pmol/l
1.94
51
230
147
1015
1.83
6.47
18.1
13.3
1.25
1.26
inr
0.11
122
845
12
14
8.86
6.11
1.3
1.2
—
—
—
0
0
290
2557
2.48
5.38
25.0
14.5
139.37
139.75
mmol/l
2.16
285
2514
289
2555
2.39
5.14
22.2
12.1
24.68
24.72
mg/l
0.01
247
2044
25
93
2.83
5.14
1.4
1.7
248.84
247.95
mu/l
0.01
25
86
8
6
13.63
5.10
1.1
1.0
—
—
—
0
0
290
2571
2.41
5.07
25.4
14.5
4.03
4.01
mmol/l
0.64
284
2522
157
1172
1.67
4.81
3.5
3.1
0.03
0.00
estimate
0.49
32
224
158
1186
1.66
4.70
3.5
3.0
0.00
0.00
estimate
-0.00
31
193
61
349
1.92
4.66
10.2
7.5
104.11
104.15
mmol/l
0.03
61
349
155
1161
1.65
4.63
3.5
3.0
0.00
0.00
estimate
-0.00
32
224
17
54
3.27
4.55
4.0
1.6
—
—
—
0
0
36
173
2.22
4.37
3.4
2.0
65.93
66.67
e9/l
0.06
25
124
98
662
1.69
4.29
3.0
2.4
368.35
379.06
umol/l
0.54
92
602
59
346
1.87
4.17
4.6
2.5
12.91
14.48
umol/l
0.86
52
325
16
52
3.19
4.14
1.6
1.3
261.86
294.21
ug/g
—
7
30
14
43
3.36
3.95
2.6
3.0
55.86
55.07
%
0.12
14
43
43
232
1.99
3.88
13.1
9.3
—
—
—
0
0
55
325
1.84
3.79
4.7
2.4
2.18
2.25
g/l
0.37
50
305
13
34
3.94
3.73
2.8
3.5
3.64
3.69
e9/l
0.03
13
34
42
229
1.96
3.68
2.0
2.2
—
—
—
0
0
25
111
2.36
3.65
1.2
1.3
—
—
—
0
0
51
300
1.83
3.56
5.0
2.5
23.64
25.27
%
0.43
46
284
43
244
1.88
3.36
1.6
1.5
—
—
—
0
0
44
253
1.86
3.30
4.3
2.7
9.24
10.35
umol/l
0.13
37
225
6
7
8.71
3.27
1.7
1.6
4.77
2.61
mg/l
—
6
7
181
1481
1.51
3.27
4.4
3.5
1.74
1.56
ug/l
0.49
160
1346
127
966
1.52
3.24
3.1
2.9
6.20
6.08
ph
0.62
79
597
16
61
2.71
3.18
1.6
1.4
—
—
—
0
0
16
61
2.71
3.18
1.5
1.4
154.00
130.50
au/ml
—
5
14
46
273
1.80
3.12
7.1
3.3
7.36
7.38
ph
2.13
35
154
37
209
1.87
2.94
2.4
1.7
377.84
378.89
nmol/l
0.01
37
194
7
13
5.48
2.88
1.4
1.0
—
—
—
0
0
44
266
1.76
2.82
7.3
3.2
1.16
1.81
mmol/l
0.68
39
230
96
708
1.51
2.76
3.3
2.5
0.00
0.00
estimate
-0.00
26
185
22
105
2.18
2.76
2.6
3.0
4.36
4.70
pmol/l
0.59
17
93
5
6
8.44
2.76
1.2
1.2
12.60
10.58
u/l
—
5
6
292
2716
1.89
2.61
21.2
10.4
—
—
—
0
0
30
165
1.90
2.59
8.2
3.2
23.40
24.47
mmol/l
1.37
30
165
21
101
2.16
2.59
1.4
1.3
—
—
—
0
0
5
7
7.23
2.56
1.2
1.0
—
—
—
0
0
44
274
1.70
2.55
7.4
3.2
5.90
5.87
kpa
0.07
44
265
50
328
1.62
2.38
3.8
2.5
—
—
—
0
0
37
224
1.74
2.37
4.9
2.4
25.03
258.43
u/l
0.54
29
185
13
53
2.51
2.30
6.8
2.9
—
—
—
0
0
54
365
1.58
2.28
2.0
2.2
—
—
—
0
0
5
9
5.62
2.22
2.0
2.4
0.62
0.61
mmol/l
—
5
9
119
949
1.41
2.20
3.5
2.9
0.00
0.00
estimate
-0.00
30
194
9
30
3.06
2.16
1.2
1.2
—
—
—
0
0
33
200
1.73
2.12
3.8
5.4
0.30
0.00
%
—
10
36
24
132
1.88
2.10
2.0
1.8
64.73
68.03
g/l
1.37
24
120
5
10
5.06
2.08
1.6
1.9
—
—
—
0
0
5
10
5.06
2.08
1.2
1.2
—
—
—
0
0
97
754
1.41
2.06
3.5
2.7
57.64
64.27
u/l
0.47
87
720
6
16
3.80
1.94
3.2
3.4
—
—
—
0
0
41
270
1.59
1.94
10.4
10.8
0.62
1.19
mmol/l
0.55
34
226
35
222
1.65
1.92
6.6
2.7
5.56
4.47
kpa
1.68
35
214
18
93
1.99
1.89
5.3
9.7
2.46
0.86
%
0.51
18
87
65
482
1.44
1.78
2.4
2.1
2.78
2.82
mg/l
0.04
55
414
41
277
1.55
1.75
10.6
10.6
7.40
7.42
ph
0.78
19
151
5
13
3.89
1.72
1.2
2.3
—
—
—
0
0
79
611
1.39
1.70
3.4
3.1
0.00
0.02
estimate
0.68
29
206
31
199
1.62
1.64
4.0
5.1
0.00
0.05
%
—
10
44
5
14
3.61
1.62
14.0
3.7
0.40
0.79
index
—
5
14
49
353
1.46
1.56
1.9
1.5
—
—
—
0
0
22
131
1.73
1.54
1.1
1.2
—
—
—
0
0
20
116
1.77
1.52
4.5
3.0
23.75
25.32
mmol/l
1.47
20
110
31
204
1.58
1.50
4.0
5.0
1.40
0.71
%
—
10
49
29
188
1.60
1.49
2.7
2.1
0.20
0.32
e6/l
0.52
29
179
10
45
2.26
1.48
6.0
3.6
—
—
—
0
0
41
289
1.48
1.46
1.2
1.3
—
—
—
0
0
7
28
2.53
1.46
3.6
2.7
—
—
—
0
0
27
173
1.61
1.45
3.2
2.8
—
—
—
0
0
26
165
1.63
1.45
13.0
11.5
1.08
1.54
%
2.46
26
165
42
299
1.47
1.43
2.2
1.7
—
—
—
0
0
30
199
1.56
1.41
3.9
4.6
0.67
0.33
%
—
9
49
25
159
1.62
1.39
13.3
11.8
0.63
0.67
%
0.23
25
159
14
75
1.91
1.36
1.4
1.2
256.13
297.46
u/ml
—
8
50
43
313
1.43
1.31
1.8
1.7
1135.23
1182.03
nmol/l
0.15
29
256
6
24
2.53
1.31
3.7
2.4
0.51
0.70
e9/l
—
6
24
5
118
0.41
1.27
1.6
1.3
—
—
—
0
0
24
155
1.59
1.27
4.0
2.5
0.62
0.60
%
0.11
24
155
113
960
1.27
1.25
3.8
3.3
59.66
52.69
ng/l
0.07
82
640
113
962
1.27
1.22
1.9
1.9
97.24
94.14
pmol/l
0.31
67
542
5
19
2.66
1.22
1.4
1.3
26.60
33.56
ng/l
—
5
19
8
38
2.13
1.19
7.0
4.3
19.23
15.11
pmol/l
—
8
38
13
222
0.57
1.19
1.2
1.8
0.35
0.30
mg/l
—
5
128
71
571
1.31
1.19
5.2
5.2
—
—
—
0
0
15
87
1.76
1.17
3.1
3.7
96.63
226.83
mg/l
—
8
42
13
72
1.84
1.17
5.8
3.2
70.12
62.34
%
0.62
13
72
18
111
1.66
1.14
1.8
1.3
—
—
—
0
0
28
393
0.68
1.11
1.3
1.3
13.23
27.44
iu/ml
—
8
116
7
31
2.29
1.11
1.3
1.2
—
—
—
0
0
5
21
2.40
1.09
1.0
1.3
0.87
0.52
ratio
—
5
12
5
23
2.19
0.98
1.8
1.0
—
—
—
0
0
5
23
2.19
0.98
1.2
1.5
—
—
—
0
0
0
31
0.00
0.97
0.0
1.4
—
350.00
—
0
5
243
2555
0.79
0.95
3.9
4.1
1.43
1.41
mmol/l
0.15
227
2420
16
102
1.60
0.92
5.8
9.2
1.91
1.57
%
0.33
16
95
6
29
2.09
0.89
2.0
1.3
—
—
—
0
0
6
29
2.09
0.89
2.7
1.8
8.57
10.48
%
—
6
29
255
2661
0.79
0.88
4.6
4.8
1.27
1.27
mmol/l
0.08
240
2531
6
30
2.02
0.87
1.2
1.1
—
—
—
0
0
233
2451
0.82
0.84
4.4
4.4
5.97
6.03
mmol/l
0.25
210
2285
98
855
1.21
0.82
2.6
2.4
0.74
0.68
ug/l
0.39
61
436
8
47
1.72
0.81
1.3
1.1
—
—
—
0
0
11
66
1.69
0.79
5.1
3.0
7.40
7.40
ph
0.07
11
66
0
27
0.00
0.78
0.0
3.1
—
—
—
0
0
257
2671
0.81
0.77
4.7
4.8
4.58
4.59
mmol/l
0.04
242
2553
7
38
1.86
0.74
6.1
2.6
9.20
8.54
kpa
—
7
38
7
38
1.86
0.74
6.1
2.6
5.27
4.88
kpa
—
7
38
5
25
2.02
0.73
2.8
2.4
4.34
4.15
mmol/l
—
5
25
5
25
2.02
0.73
2.8
2.4
1.18
1.18
mmol/l
—
5
25
5
25
2.02
0.73
1.0
1.1
257.60
278.55
mg/l
—
5
20
5
25
2.02
0.73
2.8
2.4
105.60
104.68
mmol/l
—
5
25
5
25
2.02
0.73
1.0
1.2
60.40
48.14
mg/l
—
5
19
48
580
0.80
0.73
1.4
1.3
7.16
1.10
u/ml
0.61
14
189
7
40
1.77
0.71
1.0
1.1
—
—
—
0
0
259
2685
0.81
0.71
5.0
5.3
2.78
2.81
mmol/l
0.19
249
2554
10
61
1.66
0.69
1.0
1.2
—
—
—
0
0
16
111
1.46
0.67
3.2
2.6
—
—
—
0
0
5
28
1.80
0.66
3.2
2.9
44.84
39.51
%
—
5
28
11
70
1.59
0.66
1.2
1.1
—
—
—
0
0
65
557
1.21
0.66
1.6
1.6
18.46
18.08
nmol/l
0.08
55
481
7
44
1.60
0.65
1.1
1.2
—
—
—
0
0
5
30
1.68
0.61
1.2
1.2
—
—
—
0
0
0
21
0.00
0.60
0.0
1.2
—
0.40
—
0
11
21
158
1.35
0.59
2.3
3.6
102.43
167.97
ng/l
0.92
21
140
8
54
1.49
0.57
1.0
1.1
—
112.00
—
0
14
11
73
1.52
0.57
1.0
1.2
—
—
—
0
0
19
248
0.75
0.54
1.3
3.3
—
—
—
0
0
19
248
0.75
0.54
1.3
3.3
—
—
—
0
0
19
248
0.75
0.54
1.3
3.2
—
—
—
0
0
10
66
1.53
0.53
2.1
1.7
—
—
—
0
0
119
1288
0.88
0.50
3.1
2.9
—
—
—
0
0
63
553
1.17
0.50
3.2
3.3
1.02
1.02
kg/l
0.65
41
352
19
243
0.77
0.48
1.3
3.0
—
—
—
0
0
8
116
0.68
0.46
1.0
1.1
—
—
—
0
0
20
157
1.29
0.44
2.5
1.8
6.05
6.04
ph
0.01
11
97
9
131
0.68
0.44
1.0
1.2
—
—
—
0
0
106
979
1.12
0.42
4.4
2.6
191.98
159.28
ug/l
0.84
96
925
8
59
1.36
0.41
8.1
14.4
1.19
1.26
mmol/l
—
8
53
0
17
0.00
0.41
0.0
1.8
—
17.49
—
0
17
0
18
0.00
0.40
0.0
1.1
—
15.86
—
0
5
18
225
0.79
0.39
1.3
3.5
—
—
—
0
0
0
19
0.00
0.39
0.0
1.0
—
0.36
—
0
7
11
80
1.39
0.39
1.5
2.7
17.65
11.06
mg/l
0.94
11
75
238
2450
0.89
0.38
6.4
5.9
38.75
39.32
mmol/mol
0.43
220
2346
5
37
1.36
0.37
1.4
2.9
—
—
—
0
0
11
81
1.37
0.36
1.0
1.2
—
—
—
0
0
6
42
1.44
0.35
1.2
1.4
—
—
—
0
0
6
42
1.44
0.35
1.0
1.1
—
—
—
0
0
12
91
1.33
0.34
2.9
2.8
22.82
24.73
mmol/l
0.97
12
85
37
324
1.16
0.32
2.4
2.8
4.06
4.56
e9/l
0.46
29
286
7
100
0.69
0.31
1.6
5.6
—
—
—
0
0
17
206
0.82
0.30
2.1
2.6
10.10
11.03
g/l
0.83
17
185
44
490
0.88
0.29
1.3
1.4
2.26
2.60
g/l
0.87
28
338
177
1705
1.09
0.28
3.7
3.0
14.93
14.86
pmol/l
0.12
159
1576
13
161
0.80
0.28
1.4
5.6
—
—
—
0
0
88
938
0.91
0.27
3.6
4.2
8.86
9.29
mmol/l
0.35
71
836
15
182
0.82
0.27
1.1
1.1
1.33
1.40
g/l
0.75
15
182
5
72
0.69
0.26
6.2
4.8
4.04
3.89
mmol/l
—
5
72
14
168
0.83
0.23
4.4
2.7
—
—
—
0
0
5
40
1.25
0.22
1.0
1.2
—
—
—
0
0
103
1082
0.93
0.22
2.0
2.0
1.59
1.53
mmol/l
0.29
84
945
16
188
0.84
0.22
1.3
3.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
18.58
—
0
11
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
2.1
—
—
—
0
0
5
43
1.17
0.21
1.0
1.4
—
—
—
0
0
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
11
133
0.82
0.20
1.3
1.5
—
10.98
—
0
5
35
320
1.11
0.18
1.5
1.7
3.93
3.72
mmol/l
0.32
19
236
16
184
0.86
0.17
1.1
1.1
1.00
0.96
g/l
0.27
16
184
17
193
0.87
0.16
1.2
1.2
—
—
—
0
0
13
151
0.86
0.16
1.4
1.7
1.30
1.07
g/l
0.30
13
138
20
224
0.89
0.16
1.1
1.1
—
—
—
0
0
78
817
0.94
0.16
4.7
4.8
9.38
9.77
mg/mmol
0.03
52
566
10
83
1.21
0.15
2.9
2.3
—
—
—
0
0
77
735
1.06
0.15
2.4
2.2
136.03
229.34
u/l
4.17
77
698
11
129
0.85
0.15
1.4
1.5
—
—
—
0
0
7
86
0.81
0.14
1.0
1.2
—
—
—
0
0
7
86
0.81
0.14
1.0
1.2
—
—
—
0
0
42
447
0.93
0.13
1.2
1.4
—
—
—
0
0
9
107
0.84
0.13
1.1
1.5
—
—
—
0
0
46
435
1.07
0.12
1.7
1.8
385.28
40885824.20
pmol/l
0.69
36
384
46
485
0.94
0.11
3.4
3.9
149.36
764.08
ng/l
2.29
36
360
203
2058
0.96
0.10
3.4
3.5
54.20
47.91
u/l
0.40
194
1982
78
804
0.96
0.09
3.8
4.0
44.05
64.32
mg/l
0.73
57
571
16
146
1.10
0.08
6.0
8.1
—
—
—
0
0
34
323
1.06
0.08
1.6
1.6
—
—
—
0
0
11
100
1.10
0.05
1.0
1.1
—
—
—
0
0
26
258
1.01
0.00
1.7
1.3
—
—
—
0
0
44
438
1.01
0.00
1.5
1.5
—
—
—
0
0
221
2205
1.01
0.00
4.3
3.8
1.89
1.90
mu/l
0.03
199
2052
6
59
1.02
-0.00
1.5
1.4
68.62
189.31
pmol/l
—
6
59
0
6
0.00
-0.00
0.0
4.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
34.14
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
34.58
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
57.60
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
8.6
—
25.59
—
0
9
0
6
0.00
-0.00
0.0
6.5
—
7.25
—
0
6
5
52
0.96
-0.00
4.6
2.4
1.22
1.12
g/l
—
5
42
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
6.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
3.4
—
25.14
—
0
7
0
8
0.00
-0.00
0.0
1.8
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_TESTIS_SEMINOMA – Seminoma of testis

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).